company background image
A166480 logo

CORESTEMCHEMON KOSDAQ:A166480 Stock Report

Last Price

₩12.41k

Market Cap

₩272.7b

7D

-0.08%

1Y

67.3%

Updated

20 Jul, 2024

Data

Company Financials

CORESTEMCHEMON Inc.

KOSDAQ:A166480 Stock Report

Market Cap: ₩272.7b

A166480 Stock Overview

A bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea.

A166480 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

CORESTEMCHEMON Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CORESTEMCHEMON
Historical stock prices
Current Share Price₩12,410.00
52 Week High₩14,600.00
52 Week Low₩5,250.00
Beta0.83
11 Month Change-8.75%
3 Month Change9.53%
1 Year Change67.25%
33 Year Change-32.37%
5 Year Change33.30%
Change since IPO-70.17%

Recent News & Updates

What CORESTEMCHEMON Inc.'s (KOSDAQ:166480) 26% Share Price Gain Is Not Telling You

Jun 08
What CORESTEMCHEMON Inc.'s (KOSDAQ:166480) 26% Share Price Gain Is Not Telling You

CORESTEMCHEMON Inc.'s (KOSDAQ:166480) Shares Bounce 25% But Its Business Still Trails The Industry

Mar 05
CORESTEMCHEMON Inc.'s (KOSDAQ:166480) Shares Bounce 25% But Its Business Still Trails The Industry

Recent updates

What CORESTEMCHEMON Inc.'s (KOSDAQ:166480) 26% Share Price Gain Is Not Telling You

Jun 08
What CORESTEMCHEMON Inc.'s (KOSDAQ:166480) 26% Share Price Gain Is Not Telling You

CORESTEMCHEMON Inc.'s (KOSDAQ:166480) Shares Bounce 25% But Its Business Still Trails The Industry

Mar 05
CORESTEMCHEMON Inc.'s (KOSDAQ:166480) Shares Bounce 25% But Its Business Still Trails The Industry

Does CORESTEM (KOSDAQ:166480) Have A Healthy Balance Sheet?

Apr 12
Does CORESTEM (KOSDAQ:166480) Have A Healthy Balance Sheet?

If You Had Bought CORESTEM (KOSDAQ:166480) Shares A Year Ago You'd Have Earned 59% Returns

Feb 16
If You Had Bought CORESTEM (KOSDAQ:166480) Shares A Year Ago You'd Have Earned 59% Returns

Corestem (KOSDAQ:166480) Has Debt But No Earnings; Should You Worry?

Dec 25
Corestem (KOSDAQ:166480) Has Debt But No Earnings; Should You Worry?

Shareholder Returns

A166480KR BiotechsKR Market
7D-0.08%-0.5%-2.1%
1Y67.3%25.6%4.3%

Return vs Industry: A166480 exceeded the KR Biotechs industry which returned 25.6% over the past year.

Return vs Market: A166480 exceeded the KR Market which returned 4.3% over the past year.

Price Volatility

Is A166480's price volatile compared to industry and market?
A166480 volatility
A166480 Average Weekly Movement7.2%
Biotechs Industry Average Movement8.0%
Market Average Movement4.9%
10% most volatile stocks in KR Market11.1%
10% least volatile stocks in KR Market2.2%

Stable Share Price: A166480 has not had significant price volatility in the past 3 months.

Volatility Over Time: A166480's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003376Kyung-Suk Kimwww.corestem.com

CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases.

CORESTEMCHEMON Inc. Fundamentals Summary

How do CORESTEMCHEMON's earnings and revenue compare to its market cap?
A166480 fundamental statistics
Market cap₩272.66b
Earnings (TTM)-₩26.08b
Revenue (TTM)₩29.76b

9.2x

P/S Ratio

-10.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A166480 income statement (TTM)
Revenue₩29.76b
Cost of Revenue₩30.24b
Gross Profit-₩483.21m
Other Expenses₩25.59b
Earnings-₩26.08b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.19k
Gross Margin-1.62%
Net Profit Margin-87.63%
Debt/Equity Ratio306.2%

How did A166480 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.